A client with T2DM who takes empagliflozin reports repeated … | MyMerci
MyMerci — full questions and rationale, free Start for free
Medication Administration PPT
Question

A client with T2DM who takes empagliflozin reports repeated vomiting and minimal oral intake. Which instruction should the nurse provide?

Explanation
Vomiting and reduced intake increase the risk of ketoacidosis and volume depletion with empagliflozin. The client should hold the drug, contact the prescriber, and seek urgent evaluation for symptoms such as abdominal pain or rapid breathing because ketoacidosis can occur without marked hyperglycemia. Fluid restriction, dose doubling, and stopping prescribed basal insulin can increase harm.
Next question on this topicBefore giving a scheduled dose of digoxin, the nurse obtains an apical pulse of 54/min in …

In-depth explanation

Clinical reasoning
Empagliflozin increases urinary glucose loss. Acute illness, vomiting, prolonged fasting, and dehydration can precipitate euglycemic ketoacidosis, so a near-normal glucose value does not make the symptoms safe.

Decision rule
During significant vomiting or poor intake, hold the SGLT2 inhibitor and contact the prescriber. Severe nausea, abdominal pain, dyspnea, or rapid breathing requires urgent assessment for ketoacidosis. Do not independently double the dose or stop prescribed insulin.
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.